TC BioPharm

About:

TC BioPharm develops safer, cheaper, consistent, and durable CAR-T drugs for hematological and solid tumors.

Website: http://www.tcbiopharm.com/

Twitter/X: TCBioPharm

Top Investors: SyndicateRoom, Crowdcube, Bluebird Bio, Scottish Enterprise, ScaleReady

Description:

TC BioPharm develops safer, cheaper, consistent, and durable CAR-T drugs for hematological and solid tumors. TC BioPharm’s mission is to develop and commercialize innovative cell-based products to treat disease, improving patient health and quality of life. TC BioPharm is a clinical development company with a cell-based product pipeline capable of treating a variety of disorders, including cancer and severe viral infections. TCB is currently conducting Phase II/III clinical studies of its lead product, ImmuniCell, in renal cell cancinoma, non-small cell lung cancer and melanoma patients.